Brief: Polyphor And Fosun Pharma Announce Licensing Agreement For Balixafortide In China

Spexis AG

31/08/2020 06:05

Aug 31 (Reuters) - POLYPHOR AG  POLN.S :
    * POLYPHOR AND FOSUN PHARMA ANNOUNCE EXCLUSIVE LICENSING
AGREEMENT
FOR BALIXAFORTIDE IN CHINA
    * POLYPHOR TO RECEIVE USD 15 MILLION UPFRONT PAYMENT,
DEVELOPMENT
MILESTONE PAYMENTS OF UP TO USD 19 MILLION, SALES MILESTONE
PAYMENTS OF UP TO USD 148 MILLION, AND ROYALTIES ON SALES

Source text for Eikon:  ID:nEQ1GZx9Ba 
Further company coverage:  POLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))